Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cells

Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human... In this report, we show that in the human astroglioma cell line D54‐MG, both interleukin‐1 (IL‐1β) and tumor necrosis factor‐alpha (TNF‐α) enhance C3 gene expression in a time‐ and dose‐dependent manner. Kinetic analysis demonstrates that after 96 h, C3 mRNA levels increase approximately 30‐fold and 20‐fold in response to IL‐1β or TNF‐α, respectively. C3 protein production increases proportionally, reaching levels 36‐fold and 18‐fold higher than untreated controls upon exposure to IL‐1β or TNF‐α, respectively. D54‐MG cells require a minimal 1 h exposure to IL‐1β in order to enhance C3 gene expression significantly, while 4 to 8 h are required for TNF‐α. Simultaneous treatment of D54‐MG cells with IL‐1β and interferon‐gamma (IFN‐γ) resulted in an additive increase in both C3 mRNA and protein expression, a finding not seen with the combination of TNF‐α and IFN‐γ. Primary rat astrocytes also express increased C3 mRNA levels after 48 h in response to IL‐1β (5.3‐fold increase) and TNF‐α (7‐fold increase), while an additive effect was observed upon simultaneous treatment with both IL‐1β and IFN‐γ. In the central nervous system (CNS), endogenous complement and cytokine production by astrocytes, and enhancement by IFN‐γ, a product of activated T cells often seen in the CNS in neural autoimmune disease, may contribute to the pathogenesis of inflammatory demyelinating diseases such as multiple sclerosis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Glia Wiley

Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cells

Barnum, Scott R.; Jones, Jennifer L.; Benveniste, Etty N.
Glia , Volume 7 (3) – Mar 1, 1993
Download PDF
12 pages

Loading next page...
 
/lp/wiley/interleukin-1-and-tumor-necrosis-factor-mediated-regulation-of-c3-gene-y8v1ypU1p0

References (68)

Publisher
Wiley
Copyright
Copyright © 1993 Wiley‐Liss, Inc.
ISSN
0894-1491
eISSN
1098-1136
DOI
10.1002/glia.440070306
pmid
8454308
Publisher site
See Article on Publisher Site

Abstract

In this report, we show that in the human astroglioma cell line D54‐MG, both interleukin‐1 (IL‐1β) and tumor necrosis factor‐alpha (TNF‐α) enhance C3 gene expression in a time‐ and dose‐dependent manner. Kinetic analysis demonstrates that after 96 h, C3 mRNA levels increase approximately 30‐fold and 20‐fold in response to IL‐1β or TNF‐α, respectively. C3 protein production increases proportionally, reaching levels 36‐fold and 18‐fold higher than untreated controls upon exposure to IL‐1β or TNF‐α, respectively. D54‐MG cells require a minimal 1 h exposure to IL‐1β in order to enhance C3 gene expression significantly, while 4 to 8 h are required for TNF‐α. Simultaneous treatment of D54‐MG cells with IL‐1β and interferon‐gamma (IFN‐γ) resulted in an additive increase in both C3 mRNA and protein expression, a finding not seen with the combination of TNF‐α and IFN‐γ. Primary rat astrocytes also express increased C3 mRNA levels after 48 h in response to IL‐1β (5.3‐fold increase) and TNF‐α (7‐fold increase), while an additive effect was observed upon simultaneous treatment with both IL‐1β and IFN‐γ. In the central nervous system (CNS), endogenous complement and cytokine production by astrocytes, and enhancement by IFN‐γ, a product of activated T cells often seen in the CNS in neural autoimmune disease, may contribute to the pathogenesis of inflammatory demyelinating diseases such as multiple sclerosis.

Journal

Glia – Wiley

Published: Mar 1, 1993

There are no references for this article.